ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
¤ÇÒÁÃÙéáÅÐÇÔªÒ¡ÒÃ
ÊÓËÃѺºØ¤¤Åҡ÷ҧ¡ÒÃྷÂì
àÁ¹Ù
Toggle navigation
àÁ¹Ù
˹éÒáá
ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
¾Ñ¹¸¡Ô¨ÊÁÒ¤Á
¡¯¢éͺѧ¤ÑºÊÁÒ¤Á
¤³Ð¡ÃÃÁ¡ÒúÃÔËÒÃ
»ÃÐÇѵÔÊÁÒ¤Á
ãºÊÁѤÃÊÁÒªÔ¡
¾ºËÁÍÁÐàÃç§
¶ÒÁ-µÍº ËÁÍÁÐàÃç§¹ÃÕàǪ
¤Ó¶ÒÁ·Õ辺ºèÍÂ
¤ÇÒÁÃÙéáÅÐÇÔªÒ¡ÒÃ
ÊÓËÃѺ»ÃЪҪ¹·ÑèÇä»
ÊÓËÃѺºØ¤Åҡ÷ҧ¡ÒÃá¾·Âì
ÂÒ¹èÒÃÙé
ËÍ¡ÃШÒ¢èÒÇ
§Ò¹»ÃЪØÁÇÔªÒ¡ÒõèÒ§æ
Áբͧ´ÕÁÒÍÇ´
¢èÒǨҡÊÁÒ¤Á¶Ö§ÊÁÒªÔ¡ TGCS
ÇÒÃÊÒÃ/ÃÙ»ÀÒ¾¡Ô¨¡ÃÃÁ
Fellow Club
Interinstitue Conference
Refresher Course
Log Book
Case Study Interinstitue Conference
Colposcopic case study by ¢Í§ TSCCP
Thai Endoscopic Society for Gynecologic Oncology (TESGO)
Çѵ¶Ø»ÃÐʧ¤ìªÁÃÁÏ
¤³Ð¡ÃÃÁ¡ÒêÁÃÁÏ
ãºÊÁѤÃÊÁÒªÔ¡ TESGO
¤ÇÒÁÃÙéáÅÐÇÔªÒ¡Òà TESGO
á¾·Âì·Ò§àÅ×Í¡
µÔ´µèÍàÃÒ
TGCS Song
à¾Å§ÊÁÒ¤Á
Partner Link
á¾·ÂÊÁÒ¤ÁÏ
á¾·ÂÊÀÒ
ÃÒªÇÔ·ÂÒÅÑÂÊÙµÔ¹ÃÕá¾·ÂìÏ
Check Email
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
Written by Webmaster @ TGCSThai
24 ÁÕ¹Ò¤Á 2564 14:14:34
§Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â ã¹Çѹ·Õè 2-4 µØÅÒ¤Á 2563 ³ OZO North Pattaya âçáÃÁÍÁÒÃÕ ¾Ñ·ÂÒ ¨Ñ§ËÇÑ´ªÅºØÃÕ
VDO
áÅÐä¿Åì Presentation
§Ò¹»ÃЪØÁÇÔªÒ¡ÒÃ
** ੾ÒÐá¾·Âìà·èÒ¹Ñé¹ **
¤é¹ËÒ¢éÍÁÙÅã¹àÇçºä«µì
¡ÃسҡÃÍ¡¤Ó¤é¹
Submit
Member Login
ÍÕàÁÅì¼Ùéãªé
ÃËÑʼèÒ¹
Login
ÊÁѤÃÊÁÒªÔ¡
Å×ÁÃËÑʼèÒ¹ ?
ÅçÍ¡ÍÔ¹à¢éÒãªé§Ò¹äÁèä´é ?
Official Partners
Gynecologic Cancer Knowledge
ÇѤ«Õ¹»éͧ¡Ñ¹äÇÃÑÊ COVID-19 ¡Ñº¼Ùé»èÇÂÁÐàÃç§¹ÃÕàǪ
¡ÒûÃÐàÁÔ¹¤ÇÒÁàÊÕè§·ÕèʵÃÕ¨ÐÁÕ¤ÇÒÁ¼Ô´»¡µÔ¢Í§ÂÕ¹·Ò§¾Ñ¹¸Ø¡ÃÃÁã¹âäÁÐàÃç§Ãѧä¢è
ÂÕ¹·Ò§¾Ñ¹¸Ø¡ÃÃÁ¡ÑºâäÁÐàÃç§Ãѧä¢èáÅСÒûéͧ¡Ñ¹âä
ÁÐàÃç§Ãѧä¢è¡ÑºÀÑÂà§Õºã¹ÊµÃÕ
TGCSthai
ÁÐàÃç§»Ò¡Á´ÅÙ¡ »éͧ¡Ñ¹§èÒ¡ÇèÒÃÑ¡ÉÒ
GLOBE-ATHON 2018 à´Ô¹-ÇÔè§ÁÔ¹Ô-ÎÒÅì¿ÁÒÃҸ͹ ÿÇÔè§´éÇÂã¨ãËé¹éͧ »éͧ¡Ñ¹ÁÐàÃç§»Ò¡Á´ÅÙ¡ÿ ¤ÃÑé§·Õè 4
Å×ÁÃËÑʼèÒ¹
¡ÃÍ¡ÍÕàÁÅì·Õèŧ·ÐàºÕ¹:
*
¢ÍÃËÑʼèÒ¹ãËÁè
ÅçÍ¡ÍÔ¹à¢éÒãªé§Ò¹äÁèä´é
µÃǨÊͺʶҹРaccount ´éǵ¹àͧ
Email address:
*
µÃǨÊͺ
¢ÍÃѺÍÕàÁÅìà¾×èÍ·Ó¡Òà Activate ÍÕ¡¤ÃÑé§
Email address:
*
Ê觤ӢÍ
Å×ÁÍÕàÁÅì·Õèãªéŧ·ÐàºÕ¹
¡ÃسÒãÊèÃÒÂÅÐàÍÕ´µèÒ§æ à¾×èͤé¹ËÒ¢éÍÁÙÅ
àºÍÃìâ·ÃÈѾ·ì:
*
ËÁÒÂàÅ¢ºÑµÃ»ÃЪҪ¹:
*
¤é¹ËÒ
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
1. »Ãиҹà»Ô´¡ÒûÃЪØÁ
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
2. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ The new ASCCP: What are the key changes? â´Â Kasiti Thiangtham, M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
3. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Palliative care and tele-medicine: How could we organize? â´Â Thitirath Thantiprechapong, M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
4. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ A clinical review of gestational trophoblastic disease â´Â Asst. Prof. Nida Jareemit, M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
5. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Maternal immunization: From theory to Ob-Gyn’s practice â´Â Assoc. Prof. Surasith Chaithongwongwatthana, M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
6. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ AI in cervical cancer screening...trends or our future â´Â Assoc. Prof. Wg. Cdr. Komsun Suwannarurk , M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
7. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Immunomodulatory therapy in gynecologic oncology: Becoming the new normal of practice. â´Â Yuwadee Itaarat, M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
8. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ The impact of VTE in gynecologic cancer patients : Treatment & Prevention â´Â Asst. Prof. Piyanut Pootracool, M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
9. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ New frontiers in systemic treatment of advanced endometrial cancer â´Â Prof. Siriwan Tangjitgamol, M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
10. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Role of hormonal treatment in uterine sarcoma â´Â Asst. Prof. Chalong Cheewakriangkrai, M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
11. ÁرԵҨԵ Í.ÈÔÃÔÇÃó
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
12. Oral presentation (8 min. x 11 topics)
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
13. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ PARP inhibitors for ovarian cancer : Is it time for a new treatment paradigm? â´Â Assoc. Prof.Tarinee Manchana, M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
14. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Same day surgery in gynecologic oncology â´Â Asst. Prof. Thannaporn Kittisiam, M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
15. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Post-treatment surveillance for cervical cancer â´Â Assoc.Prof. Jitti Hanprasertpong, M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
16. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ New highlights on HPV vaccination â´Â Prof. Jatupol Srisomboon, M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
17. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Presidential address â´Â Gp.Capt. Panon Kasemsarn, M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
18. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ New normal in NCCN 2020 â´Â Asst. Prof. Suttha Hamontri, M.D. áÅÐ Pattiya Nutthachote, M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
19. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Immunotherapy – A revolutionary gynecologic cancer treatment option â´Â Assoc. Prof. Arb-aroon Lertkhachonsuk, M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
20. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ From ESMO-ESGO 2020: How will it change your NORMAL practices? â´Â Natkrita Pohthipornthawat, M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
21. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Update in hormonal therapy in gynecologic cancer â´Â AVM. Sureeporn Boonjong, MD.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
22. TGCS business meeting 2020
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
23. Oral presentation (8 min. x 12 topics)
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
24. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Endometriosis management in the context of onco-gynecologist â´Â Assoc. Prof. Arb-aroon Lertkhachonsuk, M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
25. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Genetic testing in gynecologic cancers: A new normal approach in this era â´Â Asst. Prof. Atchara Tunteeratum, M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
26. ËÑÇ¢éÍ¡ÒúÃÃÂÒÂàÃ×èͧ Update in HPV vaccine and national policy for eradication of cervical cancer â´Â Suchada Jiamsiri, M.D. áÅÐ Piyawat Laowahutanont, M.D.
VDO §Ò¹»ÃЪØÁÇÔªÒ¡ÒûÃÐ¨Ó»Õ 2563 ¢Í§ÊÁÒ¤ÁÁÐàÃç§¹ÃÕàǪä·Â
27. »Ô´¡ÒûÃЪØÁ